Return On Equity of Tarsus Pharmaceuticals, Inc. from 31 Dec 2019 to 30 Sep 2025

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Tarsus Pharmaceuticals, Inc. quarterly and annual Return On Equity in % history and change rate from 31 Dec 2019 to 30 Sep 2025.
  • Tarsus Pharmaceuticals, Inc. Return On Equity for the quarter ending 30 Sep 2025 was -26%, a 53% increase year-over-year.
  • Tarsus Pharmaceuticals, Inc. annual Return On Equity for 2024 was -47%, a 37% increase from 2023.
  • Tarsus Pharmaceuticals, Inc. annual Return On Equity for 2023 was -74%, a 129% decline from 2022.
  • Tarsus Pharmaceuticals, Inc. annual Return On Equity for 2022 was -32%, a 323% decline from 2021.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Change (%)
Return On Equity, Annual (%)
Return On Equity, YoY Annual Change (%)

Tarsus Pharmaceuticals, Inc. Quarterly Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
Q3 2025 -26% +30% +53% 01 Jul 2025 30 Sep 2025
Q2 2025 -32% +32% +49% 01 Apr 2025 30 Jun 2025
Q1 2025 -40% +31% +44% 01 Jan 2025 31 Mar 2025
Q4 2024 -47% +28% +37% 01 Oct 2024 31 Dec 2024
Q3 2024 -56% +3% +5.5% 01 Jul 2024 30 Sep 2024
Q2 2024 -64% -13% -26% 01 Apr 2024 30 Jun 2024
Q1 2024 -71% -38% -115% 01 Jan 2024 31 Mar 2024
Q4 2023 -74% -42% -129% 01 Oct 2023 31 Dec 2023
Q3 2023 -59% -25% -73% 01 Jul 2023 30 Sep 2023
Q2 2023 -51% -19% -61% 01 Apr 2023 30 Jun 2023
Q1 2023 -33% -7% -28% 01 Jan 2023 31 Mar 2023
Q4 2022 -32% -25% -323% 01 Oct 2022 31 Dec 2022
Q3 2022 -34% -28% -491% 01 Jul 2022 30 Sep 2022
Q2 2022 -32% -28% -746% 01 Apr 2022 30 Jun 2022
Q1 2022 -26% -8% -43% 01 Jan 2022 31 Mar 2022
Q4 2021 -8% +75% +91% 01 Oct 2021 31 Dec 2021
Q3 2021 -6% -162% -104% 01 Jul 2021 30 Sep 2021
Q2 2021 -4% -102% -104% 01 Apr 2021 30 Jun 2021
Q1 2021 -18% -105% -121% 01 Jan 2021 31 Mar 2021
Q4 2020 -83% -189% -178% 01 Oct 2020 31 Dec 2020
Q3 2020 157% 01 Jul 2020 30 Sep 2020
Q2 2020 99% 01 Apr 2020 30 Jun 2020
Q1 2020 87% 01 Jan 2020 31 Mar 2020
Q4 2019 106% 01 Oct 2019 31 Dec 2019

Tarsus Pharmaceuticals, Inc. Annual Return On Equity (%)

Period Value YoY Chg Change % Start Date End Date
2024 -47% +28% +37% 01 Jan 2024 31 Dec 2024
2023 -74% -42% -129% 01 Jan 2023 31 Dec 2023
2022 -32% -25% -323% 01 Jan 2022 31 Dec 2022
2021 -8% +75% +91% 01 Jan 2021 31 Dec 2021
2020 -83% -189% -178% 01 Jan 2020 31 Dec 2020
2019 106% 01 Jan 2019 31 Dec 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.